Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy.

TitleGenital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy.
Publication TypeJournal Article
Year of Publication2018
AuthorsGianella S, Marconi VC, Berzins B, Benson CA, Sax P, Fichtenbaum CJ, Wilkin T, Vargas M, Deng Q, Oliveira MF, Moser C, Taiwo BO
JournalJ Acquir Immune Defic Syndr
Volume79
Issue5
Paginatione112-e114
Date Published2018 Dec 15
ISSN1944-7884
DOI10.1097/QAI.0000000000001863
Alternate JournalJ. Acquir. Immune Defic. Syndr.
PubMed ID30383591
PubMed Central IDPMC6231952
Grant ListP30 AI050409 / AI / NIAID NIH HHS / United States
UM1 AI069471 / AI / NIAID NIH HHS / United States
R21 HD094646 / HD / NICHD NIH HHS / United States
UM1 AI068634 / AI / NIAID NIH HHS / United States
P01 HD040540 / HD / NICHD NIH HHS / United States
R21 AI134295 / AI / NIAID NIH HHS / United States
P30 MH062512 / MH / NIMH NIH HHS / United States
P30 AI036214 / AI / NIAID NIH HHS / United States
UM1 AI106701 / AI / NIAID NIH HHS / United States
P30 AI117943 / AI / NIAID NIH HHS / United States
U01 AI068634 / AI / NIAID NIH HHS / United States
UM1 AI068636 / AI / NIAID NIH HHS / United States